FOUNDER AND CHAIR OF BOARD
John M. Nelson, MD
Dr. Nelson is the founder and CEO of Nelson Information Systems and JournalDoc. A graduate of Harvard, Case-Western Medical School, and the University of Chicago Business School, he is board-certified in Internal Medicine and a Fellow of the American College of Physicians and the American College of Physician Executives. John has over 25 years’ experience in the field of medical informatics and in medical research, teaching, and management. As a Staff Associate at the N.I.H., he was part of the research teams that developed the German measles (rubella) vaccine and the hepatitis B vaccine. As an Assistant Clinical Professor at the PROMIS Lab at the University of Vermont Medical School, he helped develop one of the first clinical electronic medical information systems in the U.S. John is published in leading medical journals and has been awarded six patents. Honors have included the Steuer Award for basic research in medical school, and inclusion in Who’s Who in America, Who’s Who in Finance, and Who’s Who in Health and Medicine.
BOARD OF DIRECTORS
Holly A. Edwards
Holly is a senior executive with extensive experience working with Boards in large, highly complex, strictly regulated organizations ranging from multinational Fortune 50 companies to startups. Holly has cross-industry experience in Health Care, Supply Chain and Distribution, Consulting, Technology, and Defense industries working for companies such as Blue Cross Blue Shield, UPS, Lockheed Martin, and BAE Systems. She is multi-disciplined with extensive experience in strategic technology planning, software development, process reengineering, data and analytics, IT governance, vendor management, and large-scale global technology deployments.
Holly holds an MBA from Loyola University and a Bachelor of Science in Mathematics, also from Loyola.
Lee Krause has more than 25 years of software engineering experience with the DoD, Health Care, and Information Security domains. A serial entrepreneur and founder of Securboration Inc. and Securboration Inc. spin-off Audigence Inc., Mr. Krause oversaw all elements of Audigence's founding, including the development of a highly specialized staff, marketing strategies, and securing the evolution of semantic technologies. Mr. Krause holds 10 patents associated with optimization of hearing devices.
As Rampart AI™ CEO, Mr. Krause is involved in all aspects of the company's evolution, from management to technical vision. Mr. Krause has held various software engineering roles with Harris Corp., Northrop Grumman, and Modus Operandi. His breadth of experience includes weapons system development, DoD Research and Management Consulting.
Mr. Krause holds a Bachelor of Science degree in Computer Engineering from the Rochester Institute of Technology.
Peter R. Seaver
Mr. Seaver is a partner of the Apjohn Group and a pharmaceutical industry consultant. He retired from a successful 30-year career with Pharmacia & Upjohn in 1997. A graduate of Bowdoin College, Brunswick, Maine, with a BA Degree in Biology, Mr. Seaver’s business career began with The Upjohn Company soon after he completed his service with the United States Army Medical Services Corp. He was discharged from the service as a First Lieutenant in 1966, after completion of a tour of duty in Vietnam
Peter joined The Upjohn Company as a pharmaceutical sales representative in Framingham, Massachusetts and progressed through sales and sales management positions. He was appointed a Corporate Officer and Vice President of Worldwide Pharmaceutical Marketing in January 1989 and in June of 1992 was appointed Corporate Vice President of Worldwide Strategic Marketing.
Mr. Seaver has served on multiple Board of Directors and is a Director with Nelson Information Systems.
Rose M. Arnone
Rose is an independent consultant for the healthcare industry with a focus on medical marketing. She has over 25 years of bio-pharmaceutical experience with a specialization in launch preparedness. Rose is highly skilled in identifying and executing upon game changing tactics including the use of influence mapping to accelerate product adoption. Her ability to lead successful launch planning is anchored in a disciplined and analytical approach, along with thoughtful strategic decision making. The brands that Rose has launched have all come to achieve or exceed revenue targets.
Rose’s pharmaceutical career began with Merck, where she was started out in a clinical development role before beginning the traditional industry schooling through the ranks of sales, global marketing, sales leadership, and US marketing. Rose’s experience crossed multiple therapeutic areas, including 7 new product launches. At her second company, Amgen, Rose was a critical member of the launch team for Prolia.
Rose earned a Bachelor of Science in Business Administration from New Jersey City University.
Alan is one of the Partners and a Senior Consultant at Aldebaran Group. He is also the Director of Litigation Technology. Alan brings 20 years of experience in the IT and Litigation Technology fields.
In his role at Aldebaran Group, Alan is responsible for developing technology solutions to support clients in the legal field and provides direct IT solutions through consulting, project management, implementation, and end-user support.
Prior to joining Aldebaran Group, Alan was Founder and President of Element Consulting Group, Inc., where he used computer-based litigation tools to support some of the nation’s largest corporations and financial institutions. He has consulted with dozens of law firms to develop networking and automation solutions to drive their business and manage their litigations. Alan started his career as a Manager of Corporate Franchising where he used computer networks to solve business problems.
Alan has a Degree in Business Management from the University of Massachusetts.
Mr. Staples is the Director of Strategic Cybersecurity Research at Securboration and Chief Product Officer at Rampart AI.
Over more than a decade at Securboration, Mr. Staples has led many successful research and development efforts in the cybersecurity domain. Lessons learned and technology developed under this body of work are the foundation of Rampart™, a family of defensive technologies capable of blocking attacks against operationally deployed mission-critical software.
Mr. Staples is the first named inventor of a patented technique for automatically parallelizing sequential software and is a named inventor on a patent for deceptive polymorphic network architectures and another for secure computing environment architectures. Mr. Staples' current focus is on the continued enhancement of the Rampart product line to meet his long-term goal of providing advanced tools that can defend against emergent threats to enterprise software.
Mr. Staples holds an M.S. in Computer Engineering from the University of Central Florida (2011) and a B.S. in Computer Science from Midwestern State University (2009). While at UCF, he researched dynamic power gating techniques that could improve the energy efficiency of modern superscalar processors. His advisor at UCF was Dr. Mark Heinrich, a protégé of Dr. John Hennessy, former president of Stanford University and 2017 A.M. Turing Award recipient.